Former Executive Vice President, Finance MDxHealth
Life Science Partner recruited Francis Ota to become the Chief Financial Officer at Lineagen, an innovative genetics diagnostics company for neurodevelopmental disorders. Ota joins Lineagen after serving as the Executive Vice President of Finance for MDxHealth, a publically owned Belgium based diagnostic company with a US CLIA lab that develops epigenetic tests for cancer assessments.
During his tenure at MDxHealth, Ota played a key role in generating profitable growth, raising capital and negotiating M&A transactions. Earlier in his career he held financial leadership roles at Focus Diagnostics (acquired by Quest), QUAD Research, and Medtronic among others.
“As a global leader in finance, Ota has overseen the financial management of a CLIA laboratory from rapid growth through exit via acquisition,” states Tom Callaway, MD, President of Life Science Partner. “With his solid understanding of the reimbursement and revenue management challenges of a CLIA lab, Ota will serve as a critical member of Lineagen’s leadership team.”
Ota earned his Bachelor of Science Degree in Finance and International Business from the University of Colorado and his MBA from the University of California.